Multimodal pathology foundation model that aligns whole-slide images with genomic, epigenetic, and transcriptomic data for richer patient-level representations.
EXAONE Path 2.5 is a multimodal pathology foundation model from LG AI Research that enriches histopathology representations by aligning whole-slide images (WSIs) with multiple layers of molecular data — genomic, epigenetic, and transcriptomic. Rather than learning from imaging alone, it produces an integrated patient representation grounded in tumor biology by jointly modeling histology and multi-omics signals in a shared embedding space. Released as an arXiv preprint in December 2025, it continues the EXAONE Path lineage, following the patch-level EXAONEPath 1.0 and the end-to-end supervised EXAONE Path 2.0.
Computational pathology has converged on large self-supervised image models, but most such models see only pixels and miss the molecular context that drives cancer behavior. EXAONE Path 2.5 addresses this gap by treating histology and multi-omics as complementary views of the same patient and forcing them into alignment during training. The result is an embedding intended to reflect underlying tumor biology more comprehensively than image-only foundation models, while remaining usable from a slide alone at inference time.
The model is positioned for the growing set of clinical and translational tasks where morphology and molecular state interact — biomarker inference, subtyping, and outcome prediction — and is released with open weights on HuggingFace under a non-commercial license.
EXAONE Path 2.5 uses a two-stage inference pipeline: a patch encoder extracts embeddings from image patches (224×224 pixels), and a slide encoder aggregates patch-level features into a slide representation using spatial coordinates and tissue-contour information, with F-RoPE preserving spatial topology. During training, the multimodal SigLIP loss aligns these slide representations with embeddings from domain-specialized WSI and RNA-seq encoders across genomic, epigenetic, and transcriptomic modalities. The authors report that the approach matches or surpasses state-of-the-art pathology foundation models while using substantially fewer training samples and parameters than existing approaches. It was evaluated against six leading pathology foundation models on two complementary benchmarks: an internal multi-institutional real-world clinical dataset and Patho-Bench, a public suite of 80 tasks. (Exact parameter counts and per-task scores are not disclosed in the available materials.)
EXAONE Path 2.5 targets computational pathology workflows where molecular context improves analysis of routine histology, including cancer subtyping, molecular biomarker prediction, and survival/outcome prediction from whole-slide images. Because the multi-omics knowledge is distilled into a slide-only representation, pathologists and translational researchers can apply it to standard H&E slides without requiring paired sequencing at inference, making it suitable for retrospective cohort analysis and as a feature extractor for downstream clinical prediction tasks.
EXAONE Path 2.5 is part of a broader shift in computational pathology toward biologically grounded, multimodal foundation models that move beyond image-only self-supervision. By demonstrating competitive performance on the 80-task Patho-Bench suite with reportedly lower data and parameter requirements, it offers an efficiency-oriented alternative to larger image-only models. The open release of weights on HuggingFace lowers the barrier for academic adoption, though the non-commercial license and as-yet-undisclosed training data scale limit direct clinical deployment and full reproducibility.
Papers that recently cited this model.
The most-cited papers that cite this model.
Not enough data